Liver Function and Body Mass Index in Women with Breast Cancer in Nineveh Governorate, Iraq

Breast Cancer is one of the most prevalent cancers in the world to strike women is breast cancer, and its death rates are rising. This study's objective is to evaluate how breast cancer impacts liver function within affected women in Nineveh Governorate, Iraq, in relation to body mass index (BMI). Between October 2024 and January 2025, 55 samples were collected from the Oncology and Nuclear Medicine Hospital in Mosul. There were 20 healthy women and 35 patients with breast cancer. The study was conducted at the Oncology and Nuclear Medicine Hospital in Nineveh Governorate, Iraq, and the ages of the patients varied in age from 14 to 75 years. Individuals using a history of diabetes, liver disease, or other chronic conditions were not included. The findings indicated a notable rise in other concentrations (p < 0.05). Biochemical indicators were compared. Patients with breast cancer were evaluated against a control group. This is a possibility that has been suggested, the relationship between cancer development and obesity, to improve disease management and treatment methods. This data highlights the importance of tracking liver functions and body mass index among people who have breast cancer. The current study showed that among women of childbearing age, there is a significant increase in genetic changes in estrogen and progesterone levels with aging (55-75). The effects of the findings are emphasized in connection with the hormones progesterone and estrogen. Furthermore, the effects of chemotherapy on various biochemical markers are examined.